Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts-Reference-Cited by-同舟云学术

Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts

Published:2017-05-31 Issue:392 Volume:9 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Miller Miles A.¹²^ORCID,Chandra Ravi¹³,Cuccarese Michael F.¹^ORCID,Pfirschke Christina¹,Engblom Camilla¹,Stapleton Shawn¹^ORCID,Adhikary Utsarga¹,Kohler Rainer H.¹^ORCID,Mohan James F.¹,Pittet Mikael J.¹²^ORCID,Weissleder Ralph¹²⁴^ORCID

Affiliation:

1. Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, MA 02114, USA.

2. Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.

3. Harvard Radiation Oncology Program, 55 Fruit Street, Boston, MA 02114, USA.

4. Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA.

Abstract

Radiation therapy enhances nanotherapeutic drug delivery in a tumor-associated macrophage–dependent fashion.

Funder

Foundation for the National Institutes of Health

National Cancer Institute

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference40 articles.

1. Clinical Translation of Nanomedicine

2. Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

3. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle

4. Analysis of nanoparticle delivery to tumours

5. Abstract CT234: A phase I study of MM-302, a HER2-targeted PEGylated liposomal doxorubicin, in patients with HER2+ metastatic breast cancer;LoRusso P.;Cancer Res.,2015

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the nanoscale: Principles of body navigation;Nanotechnology Tools for Infection Control;2025

2. Systemically targeting monocytic myeloid-derived suppressor cells using dendrimers and their cell-level biodistribution kinetics;Journal of Controlled Release;2024-10

3. Smart Cancer Nanomedicine for Synergetic Therapy;Current Medicinal Chemistry;2024-06-10

4. Radiation-primed TGF-β trapping by engineered extracellular vesicles for targeted glioblastoma therapy;Journal of Controlled Release;2024-06

5. Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions;ACS Nano;2024-05-20